The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion

Background Drug-disease interactions negatively affect the benefit/risk ratio of drugs for specific populations. In these conditions drugs should be avoided, adjusted, or accompanied by extra monitoring. The motivation for many drug-disease interactions in the Summary of Product Characteristics (SmP...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Frontiers in pharmacology 2020-05, Vol.11, p.707, Article 707
Hauptverfasser:	van Tongeren, Justine M. Z., Harkes-Idzinga, S. Froukje, van der Sijs, Heleen, Atiqi, Roya, van den Bemt, Bart J. F., Draijer, L. Willem, Hiel, Deline, Kerremans, Adrian, Kremers, Bart, de Leeuw, Marc, Olthoff, Marleen V., Pham, T. Kim-Loan, Valentijn-Robertz, Ricky, Tsoi, Kayan, Wichers, Iris, de Wit, Maaike, Borgsteede, Sander D.
Format:	Artikel
Sprache:	eng
Schlagworte:	clinical decision support drug-disease interactions expert opinion Life Sciences & Biomedicine literature review Pharmacology Pharmacology & Pharmacy practice recommendations Science & Technology study protocol
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!